Fig. 2From: Analysis of gene expression levels and their impact on survival in 31 cancer-types patients identifies novel prognostic markers and suggests unexplored immunotherapy treatment options in a wide range of malignanciesPrincipal Component Analysis of the Profile-A, Profile-B and Profile-C in SKCM, PAAD and TGCT cancers, respectively. The 3 profiles effectively discriminate patients from controls, in SKCM, PAAD and TGCT, respectively, while they are ineffective in LUAD, PRAD and THCA cancersBack to article page